Trials / Completed
CompletedNCT03087877
Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- DexCom, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to demonstrate effectiveness of the G6 sensor membrane, in preventing acetaminophen's interference effect on glucose sensing.
Detailed description
The interference effect of the sensor will be evaluated by comparing the bias in the glucose values exhibited from the G6 CGM system after administration of acetaminophen. Bias will be evaluated by comparing CGM values to a laboratory referenceusing venous sample measurements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Acetaminophen Challenge (G6 CGM) | Evaluation of acetaminophen effect on CGM glucose sensing |
Timeline
- Start date
- 2017-02-03
- Primary completion
- 2017-03-04
- Completion
- 2017-03-04
- First posted
- 2017-03-23
- Last updated
- 2018-12-31
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03087877. Inclusion in this directory is not an endorsement.